Aspirin – Complete Information You Should Know

Acetylsalicylic acid, commercially marketed as aspirin, represents a synthetic derivative of salicylic acid renowned for its well-documented analgesic, anti-inflammatory, and antipyretic properties. Classified within the non-steroidal anti-inflammatory drug (NSAID) category, it has achieved global recognition as one of the most frequently utilized pharmaceutical agents. The compound was first successfully synthesized in its pure, stable form in 1859 by the chemist Hermann Kolbe, who subsequently published a comprehensive methodology for its artificial production. Nevertheless, the precise molecular mechanism underlying its therapeutic effects remained elusive until the groundbreaking pharmacological investigations conducted by John Vane and his research team during the 1970s. Their studies demonstrated that aspirin exerts its primary action through the irreversible inhibition of cyclooxygenase (COX) enzymes, thereby suppressing prostaglandin synthesis—a critical pathway in both inflammatory responses and nociceptive signaling. This discovery, which earned Vane the 1982 Nobel Prize in Physiology or Medicine, fundamentally transformed the scientific understanding of pain management. Clinical evidence consistently highlights aspirin’s exceptional efficacy in alleviating migraine headaches and tension-type cephalalgia, with meta-analyses of randomized controlled trials frequently indicating superior performance compared to paracetamol (acetaminophen) in these indications. Similar to other NSAIDs, aspirin is employed in the symptomatic treatment of joint pain, though it is essential to emphasize that pharmacological intervention represents merely one component of a multidisciplinary approach—where non-pharmacological modalities such as physical therapy remain first-line interventions. Additionally, its antispasmodic properties render it a widely recommended option for mitigating dysmenorrhea, as it effectively relaxes uterine smooth muscle contractions, thereby attenuating associated pain symptoms.

The administration of acetylsalicylic acid is strictly contraindicated in patients exhibiting hypersensitivity to salicylates or salicylic acid, as well as in individuals with coagulation disorders characterized by a predisposition to bleeding. Its use is prohibited in cases of active peptic ulcer disease affecting the stomach or duodenum, alongside severe renal, cardiac, or hepatic insufficiency. An additional exclusion criterion includes documented instances of salicylate-induced bronchial asthma confirmed during medical evaluation. The medication must be categorically avoided by patients concurrently receiving methotrexate at dosages of 15 mg per week or higher, by women in the third trimester of pregnancy, and by children who have not yet reached their 12th year. Conversely, the drug is indicated for the management of mild to moderate pain and the reduction of elevated body temperature. Nevertheless, prior to initiating treatment, a mandatory consultation with a physician or pharmacist is required to conduct an individualized benefit-risk assessment, taking into account the patient’s comprehensive clinical profile.

The medication must always be used strictly in accordance with the instructions provided in the accompanying patient information leaflet or as directed by a qualified healthcare practitioner or pharmacist. For adult patients, the standard recommended single dose ranges from one to two tablets—equivalent to five hundred to one thousand milligrams of the active ingredient, acetylsalicylic acid. Should repeated administration be necessary, the interval between successive doses must not be shorter than four hours nor exceed eight hours. The maximum permissible daily intake is limited to eight tablets, corresponding to four grams (4000 mg) of acetylsalicylic acid. In the case of adolescent patients aged twelve years and above, the use of this medication is permissible solely under explicit medical prescription or guidance. Here, the single dose consists of one tablet containing five hundred milligrams of the active compound, with the possibility of repetition no more frequently than every four to eight hours; the total daily intake must not exceed three tablets (1500 mg). It is critical to emphasize that prior to initiating treatment, consultation with a healthcare provider is mandatory regardless of the patient’s age. Tablets should be administered orally, preferably following a meal, and accompanied by a generous amount of liquid—water being the preferred choice.

Acetylsalicylic acid (ASA), commonly referred to as aspirin, exhibits the potential for both pharmacokinetic and pharmacodynamic interactions with a broad range of therapeutic agents, which may alter their therapeutic efficacy or exacerbate adverse reactions. Particular caution is warranted when co-administered with glucocorticoids or non-steroidal anti-inflammatory drugs (NSAIDs), as this combination substantially elevates the likelihood of gastrointestinal mucosal damage—including ulcerations, erosions, or internal hemorrhage. Consequently, it is imperative that patients disclose to their healthcare provider or pharmacist a comprehensive list of all medications taken on a regular or as-needed basis, including dietary supplements and herbal products, which may similarly influence drug metabolism and clearance.

As is the case with the majority of pharmacological agents, acetylsalicylic acid may—though not inevitably—induce a spectrum of adverse reactions ranging from mild to severe in intensity. Any concerning symptoms should be promptly discussed with the prescribing physician or the specialist overseeing the treatment regimen. According to official product monographs and patient information leaflets, the most commonly reported side effects include: epigastric and abdominal pain, retrosternal burning sensation (heartburn), episodes of nausea, vomiting of varying severity, dyspeptic disturbances (impaired digestion), inflammatory conditions affecting the gastrointestinal mucosa, and—most critically—gastrointestinal hemorrhage originating from either the upper or lower tract, which may pose an immediate threat to life (manifesting as, for instance, "coffee-ground" emesis, gastric or duodenal ulceration, or even perforation of the intestinal wall). Medical literature further documents isolated instances of transient hepatic dysfunction, characterized by elevated biochemical markers. More frequently observed, albeit generally milder, symptoms of overdose include vertigo and tinnitus (ringing in the ears), which may intensify in correlation with rising serum concentrations of the drug. Acetylsalicylic acid also exerts a pronounced effect on the coagulation cascade—it enhances bleeding propensity, prolongs bleeding time, and may result in ecchymosis, subcutaneous or internal hematomas, and, in extreme cases, hemorrhagic stroke (particularly in individuals with uncontrolled hypertension or those concurrently taking other anticoagulants such as warfarin or direct oral anticoagulants). Among the less common but potentially severe complications are acute or chronic renal impairment, which may progress to kidney failure. Hypersensitivity reactions are also possible, including bronchospasm in individuals predisposed to aspirin-exacerbated respiratory disease (the so-called "aspirin triad": nasal polyps, bronchial asthma, and intolerance to nonsteroidal anti-inflammatory drugs).

To diminish the potential hazards associated with acetylsalicylic acid administration—particularly those pertaining to gastrointestinal mucosal damage and the development of ulcerative lesions—it is advisable to utilize the lowest therapeutically effective dosage of the medication. Equally critical is the consistent monitoring of circulatory parameters, including arterial blood pressure, throughout the pharmacological regimen. Furthermore, the implementation of lifestyle modifications is paramount; these include the complete abstention from high-proof alcoholic beverages, the reduction of tobacco smoke exposure, the maintenance of a healthy body weight through balanced nutrition, and the engagement in regular, moderate physical exercise. Proactive collaboration with the healthcare team—comprising the attending physician and pharmacist—facilitates the personalized adjustment of the treatment protocol, which substantially reduces the likelihood of adverse drug reactions while concurrently enhancing the overall efficacy of the therapeutic intervention.

The pharmacological classification system for medications used during pregnancy enables an assessment of potential fetal risks associated with maternal drug exposure. **Acetylsalicylic acid** (commonly referred to as aspirin) is subject to **strict risk stratification criteria** that vary according to the trimester of gestation. During the **first and second trimesters**, this compound is assigned to **Category C**, indicating that **animal studies have demonstrated teratogenic or embryolethal effects**, yet **there is an absence of well-controlled human trials**—or existing studies fail to meet rigorous scientific standards. Consequently, **aspirin should only be administered when the maternal health benefits substantially outweigh the potential fetal hazards**. In contrast, during the **third trimester**, acetylsalicylic acid is classified under **Category D**, reflecting **documented evidence of human fetal risk**, including complications such as **prolonged labor and perinatal hemorrhage**. Its use in this period is **strictly limited to life-threatening maternal conditions** where alternative treatments are either ineffective or unavailable. It is noteworthy that **salicylic acid**, first isolated in the 19th century, remains a focal point of **ongoing scientific inquiry**, with research aimed at expanding its therapeutic applications while mitigating adverse effects. Future advancements may yield **paradigm-shifting modifications to clinical protocols**, facilitating safer and more versatile use of this compound across medical specialties.